Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Collagen Cross-Linking in Eyes With Corneal Thinning Conditions

NCT04401865 is registered in ClinicalTrials.gov with Colorado Eye Consultants/Cornea Consultants of Colorado as lead sponsor.

NCT NCT04401865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04401865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Collagen Cross-Linking in Eyes With Corneal Thinning Conditions
Lead sponsor
Colorado Eye Consultants/Cornea Consultants of Colorado
Phase
Phase 1/2
Overall status
Unknown status
Start date
June 1, 2020
Completion date
June 30, 2023
Enrollment
300 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

corneal ectasia, keratoconus, pellucid marginal corneal degeneration